WiCON | Pharma China (Web Edition)

The Market

Industry News

Regulatory News

General Health

	Chinese Patents of Taxotere Invalidated by SIPO’s Patent Review Bo...
	The Patent Review Board of the State Intellectual Property Office (SIPO) recently invalidated all Chinese patents of SA’s Taxotere (Docetaxel) ... (5/8/2008 7)

MNCs Dominate Tianjin’s Diabetes Hospital Market in 2007 (4/30/2008 )

Retail Sales Growth of Vascular Drugs in Wuhan, Chengdu and Nanjing Slows in 2007 (4/30/2008 )

Bumpy Road ahead Following Sharp Growth in 2007 (4/25/2008 )

Case Study – Legal and Ethical Implications of ELAD Clinical Trial Death (4/23/2008 )

After Building Careers Here, Chinese Researchers Drawn Home (4/17/2008 )

Monitoring China''s Therapeutic Trends in Diabetes, Heptitis B and Oncology (4/14/2008 )

Prospects and Importance of China Up as Market Environment Improves (4/14/2008 )

NDRC Faces Serious Challenges for Its Pricing Policy of Off-patent Innovative Drugs (4/9/2008 3)

Drug Makers Fusing East with West (4/7/2008 4)

Proposed Management Buyout of Tongjitang Chinese Medicines Company (4/7/2008 1)

Hospital Drug Consumption in First Three Quarters of 2007 Up Sharply (4/2/2008 1)

Developing China''s Essential Drug Policy - One of Four Initiatives Under the New Healthcare Reform Scheme (4/2/2008 8)

Indepth Analysis: Leading Chinese Retail Pharmacy Chains in 2007 (3/31/2008 )

Importance of China Rises as Global Pharma Industry Restructures (3/24/2008 )

The Era of Multi-channel Communication: Engaging in a Dialogue with Stakeholders (3/24/2008 )


	China to Accelerate Review of Innovative New Drugs (5/8/2008 1)
	Chinese Patents of Taxotere Invalidated by SIPO’s Patent Review Board (5/8/2008 7)
	SFDA Accepts BMP Sunstone's Clinical Trial Application for Enablex (5/7/2008 1)
	WuXi PharmaTech Postpones Follow-on Public Offering (5/7/2008 1)
	AMDL to Acquire Guangzhou Lazon Pharma (5/7/2008 1) (free)
	New Corruption Scandal in Guangdong Expose Problems with Centralized Purchase System for Vaccines (5/7/2008 1)
	SFDA Publishes Draft of “Provisions on National Drug Codes” (5/7/2008 1)
	Baxter Scolded for Non-cooperation as China Denies Direct Link between Contaminant and US Heparin Deaths (5/7/2008 1)

	NDRC Faces Serious Challenges for Its Pricing Policy of ...
	Indepth Analysis: Leading Chinese Retail Pharmacy Chains...
	Healthcare Related Excerpts of Premier Wen Jiabao''s Gov...
	Government Reform May Start with ''Super-sizing'' the MO...
	Health Minister Chen Zhu Delivers Government Report on H...

	Export of Medicine and Health Products Rose Sharply in 1Q/2008
	Export of Medicines and Health Products Fell at Guangzhou Trade...
	Market Overview: Diabetes Therapy and Drug Consumption in China...
	Plant-Based Medicines May Become Popular Again for BPH Treatmen...
	CROs in Asia Pacific to Experience Sharp Growth

	SFDA Accepts BMP Sunstone's Clinical Trial Application for E...
	WuXi PharmaTech Postpones Follow-on Public Offering
	AMDL to Acquire Guangzhou Lazon Pharma
	New Corruption Scandal in Guangdong Expose Problems with Cen...
	GSK Restructures and Forms An "Emerging Markets" Unit

	China to Accelerate Review of Innovative New Drugs
	SFDA Publishes Draft of “Provisions on National Drug Co...
	Baxter Scolded for Non-cooperation as China Denies Direc...
	NDRC to Set Prices of Vaccines under State Immunization ...
	China and U.S. Clash Over Cause of Heparin Deaths

	Chinese Patents of Taxotere Invalidated by SIPO’s Patent Re...
	International Pharmaceutical Technology Transfer Platform Es...
	Pfizer Loses “Wei Ge” Trademark Lawsuit
	SFDA Issues No.129 Announcement of Drug Administrative prote...
	1,001 Commercial Bribery Cases in Health Sector Investigated...

	Rising Costs of Chinese Bulk Drugs to Push Up Indian Dru...
	Shandong Lunan’s New 7-ADCA Plant Becomes Operational
	Output and Export Volume of Major Antibiotic APIs by Chi...
	China's Penicillin G Export in 2007 – Volume Fell While...
	Ranking of Chinese Bulk Vitamin C Exporters in 2007

	Silver Nano-particles Found to be Effective Against HBV
	Aida Develops New Cancer Drug
	USFDA to Accept Chinese Data as Supporting Info for New ...
	Frontier Initiates Clinical Trial of Long-acting HIV Fus...
	MSD Launches Arcoxia in China

	MOH Release Results of Third National Survey for Causes ...
	Shenzhen to Launch Its Own Healthcare Reform Plan in Jun...
	Healthcare Reform Plan To Be Published After the Beijing...
	MOH Releases 2007 Health Sector Development Statistics
	WellPoint Eyes Chinese Health Insurance Market

	Chinese Health Minister to Receive Honorary Degree fro Mou...
	Shengtai Pharmaceutical, Inc. Appoints New CFO
	Appeal of Senior Jilin Drug Administration Official Denied...
	New Director of Beijing Municipal Health Department Appoin...
	Head of USFDA China Office Named

	Chinese Netizens Call for Boycott of Sanofi Aventis
	US Official Scolds China's Drug Regulation but Cheers Op...
	Upcoming Event: Biopharma Opportunities China Forum 2008...
	Upcoming Event - Pharma China Forum 1Q/2008 on April 11 ...
	Chinese Healthcare Sector Popular to Venture Capitalists...

WiCON | Pharma China (Web Edition) brings China healthcare news to you as and when they happen. Our subscribers can access the online news service at our website anytime and anywhere. Subscriber...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

Upcoming Event - Pharma China ...

Pharma China Officially Launch...

Pharma China Chief Editor Jame...

Dr. Ming Pang Joins Pharma Chi...

Pharma China Announces the Lau...

Site map | Contact Us | Links